Claudio Bravo, MD, MSc Profile
Claudio Bravo, MD, MSc

@Claudio_BravoMD

Followers
74
Following
7
Media
0
Statuses
11

Heart Failure Cardiologist || Physician-Scientist || Transplant Medical Director at Medical City Dallas

Dallas, TX
Joined January 2024
Don't wanna be here? Send us removal request.
@UCSFCardiology
UCSF Cardiology
10 months
Welcome @Claudio_BravoMD to the #UCSFCardiology faculty starting in June. Dr. Bravo completed his CV disease fellowship at @MontefioreNYC & Advanced HF at @Columbia. He holds an MS in Epidemiology from @UW. We are excited to have him join the @UCSFHospitals heart failure team!
0
4
29
@Claudio_BravoMD
Claudio Bravo, MD, MSc
1 year
This is an important step forward in understanding the underlying molecular mechanisms of RV dysfunction in patients with PAH. Proteomic Signatures of Right Ventricular Outcomes in Pulmonary Arterial Hypertension | Circulation: Heart Failure
Tweet card summary image
ahajournals.org
BACKGROUND: Pulmonary arterial hypertension (PAH) is a disease of progressive right ventricular (RV) failure with high morbidity and mortality. Our goal is to investigate proteomic features and...
0
0
0
@Claudio_BravoMD
Claudio Bravo, MD, MSc
2 years
Addressing fundamental questions about the unique features of atherosclerotic disease in people living with HIV with or without HCV. Thanks to all contributors to this great manuscript! https://t.co/luNkTXeiWN
Tweet card summary image
ahajournals.org
BACKGROUND: HIV and hepatitis C virus (HCV) are associated with increased risk of carotid artery atherosclerotic plaque and stroke. We examined associations of HIV- and HCV-related factors with...
0
0
0
@Claudio_BravoMD
Claudio Bravo, MD, MSc
2 years
Association of HIV and HCV Infection With Carotid Artery Plaque Echomorphology in the MACS/WIHS Combined Cohort Study | Stroke
Tweet card summary image
ahajournals.org
BACKGROUND: HIV and hepatitis C virus (HCV) are associated with increased risk of carotid artery atherosclerotic plaque and stroke. We examined associations of HIV- and HCV-related factors with...
0
0
0
@Ruddens2
.
2 years
@satoshivm $SAVM IS HERE TO STAY All users are invited to check eligibility and register for the upcoming NFT collection ⟶ Registration is open until January 30th ⟶ Limit of three wallets per user Register Now ⤵️ https://t.co/jqZjM49ZGx
570
52K
54K
@Ruddens2
.
2 years
@satoshivm $SAVM IS HERE TO STAY All users are invited to check eligibility and register for the upcoming NFT collection ⟶ Registration is open until January 27th ⟶ Limit of three wallets per user Register Now ⤵️ https://t.co/jqZjM49ZGx
10
27K
27K
@LorenzoBragh
Lorenzo Braghieri, MD 🇮🇹🇺🇸🇪🇺
2 years
The🫀transplant allocation system was changed to prioritize the most unstable pts. Uncomplicated LVAD pts were placed in lower priority status. Here we present the most updated outcomes from the UNOS database @lisong2003 @DrClaudiusMahr #ClaudioBravo @Mud_Fud @asaiojournal
3
10
32